β- d -Arabinofuranose-configured Cyclitol Aziridines as Selective, Brain-penetrant Covalent GBA2 Inhibitors
En palabras de los autores
Abstract Neutral glucosylceramidase GBA2 is a retaining β-d-glucosidase involved in sphingolipid metabolism and implicated in neurological lysosomal storage disorders, yet the lack of highly selective chemical inhibitors has hindered efforts to disentangle its function from that of glucosylceramide synthase (GCS) and lysosomal glucosylceramidase (GBA1). Here, we report the development of the first brain-penetrant, covalent inhibitor that selectively inactivates GBA2 in vivo. Building on β-d-arabinofuranose-configured (β-d-Araf) cyclitol aziridine activity-based probes previously shown to covalently and selectively label GBA2, we designed and synthesized a focused library of electrophile-bearing cyclitols, including epoxides, cyclic sulfates, and a diverse set of N-alkyl aziridines. Biochemical evaluation of their inhibitory activity against GBA1, GBA2, GBA3 and GCS revealed that several N-alkyl aziridines are highly selective, nanomolar GBA2 inhibitors. Lead compounds also demonstrated metabolic stability in murine plasma, robust cellular activity and high selectivity in living cells, with no detectable GCS inhibition. Notably, octyl-alkyne aziridine 5 selectively inhibited GBA2 in mouse brain, representing the first covalent GBA2 inhibitor with demonstrated in vivo activity and brain permeability. Together, these results establish β-d-Araf cyclitol aziridine 5 as a versatile inhibitor for selective, covalent GBA2 inhibition, well suited to dissect GBA2 biology in vivo, particularly in neurological lysosomal storage disorders.
En palabras simples Resumen con IA
GBA2 es una enzima involucrada en el metabolismo de grasas y vinculada a enfermedades cerebrales, pero faltaban inhibidores selectivos. Diseñaron y probaron varios compuestos, encontrando que varios N-alquil aziridinas inhiben GBA2 a concentraciones nanomolares con alta selectividad. Los compuestos principales permanecieron estables en sangre de ratón, funcionaron bien en células y no inhibieron GCS. El compuesto 5 inhibió específicamente GBA2 en cerebro de ratón, haciéndolo útil para estudiar GBA2 en enfermedades cerebrales.
Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale. Se eliminó 1 oración por no estar respaldada por el abstract.
Apareció: jueves, 1 de octubre. Journal of the American Chemical Society. Revista con revisión por pares.
DOI: 10.1021/jacs.6c09754